Advanced Therapy Medicinal Products in type I diabetes mellitus: technological and regulatory challenges
Introduction: Type 1 Diabetes mellitus (T1DM) is an autoimmune disorder which arises from the destruction of insulin-producing pancreatic β-cells. Currently, Brazil’s advanced therapy medicinal products (ATMP), developed for clinical research and therapeutic purposes, take place in the so-called Cel...
Na minha lista:
| Publicado no: | Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Fundação Oswaldo Cruz
2018
|
| Assuntos: | |
| Acesso em linha: | https://www.redalyc.org/articulo.oa?id=570563069006 https://www.redalyc.org/journal/5705/570563069006/ https://www.redalyc.org/journal/5705/570563069006/html/ https://www.redalyc.org/journal/5705/570563069006/570563069006.epub https://www.redalyc.org/journal/5705/570563069006/movil |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|